ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 138 filers reported holding ACCELERON PHARMA INC in Q2 2016. The put-call ratio across all filers is 6.11 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $57,000 | +78.1% | 1,063 | +33.9% | 0.00% | – |
Q3 2019 | $32,000 | +10.3% | 794 | +17.1% | 0.00% | – |
Q2 2019 | $29,000 | -9.4% | 678 | 0.0% | 0.00% | – |
Q1 2019 | $32,000 | +23.1% | 678 | +17.3% | 0.00% | – |
Q4 2018 | $26,000 | +225.0% | 578 | +328.1% | 0.00% | – |
Q3 2018 | $8,000 | +33.3% | 135 | -1.5% | 0.00% | – |
Q2 2018 | $6,000 | 0.0% | 137 | 0.0% | 0.00% | – |
Q1 2018 | $6,000 | 0.0% | 137 | 0.0% | 0.00% | – |
Q4 2017 | $6,000 | +50.0% | 137 | +44.2% | 0.00% | – |
Q3 2017 | $4,000 | +33.3% | 95 | 0.0% | 0.00% | – |
Q2 2017 | $3,000 | +50.0% | 95 | 0.0% | 0.00% | – |
Q1 2017 | $2,000 | -50.0% | 95 | -18.8% | 0.00% | – |
Q4 2016 | $4,000 | 0.0% | 117 | +3.5% | 0.00% | – |
Q3 2016 | $4,000 | – | 113 | +769.2% | 0.00% | – |
Q2 2016 | $0 | – | 13 | 0.0% | 0.00% | – |
Q1 2016 | $0 | -100.0% | 13 | -53.6% | 0.00% | – |
Q4 2015 | $1,000 | – | 28 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 42,030 | $3,777,000 | 6.01% |
Artal Group S.A. | 1,500,000 | $134,805,000 | 5.70% |
GREAT POINT PARTNERS LLC | 535,627 | $48,137,000 | 5.03% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 211,038 | $18,966,000 | 3.47% |
Cormorant Asset Management, LP | 825,000 | $74,143,000 | 3.44% |
Graticule Asia Macro Advisors LLC | 48,700 | $4,377,000 | 3.20% |
Avoro Capital Advisors LLC | 860,000 | $77,288,000 | 2.61% |
QVT Financial LP | 120,264 | $10,808,000 | 2.52% |
Ikarian Capital, LLC | 316,900 | $28,480,000 | 2.14% |
Avidity Partners Management LP | 166,000 | $14,918,000 | 2.06% |